RxDoctor Payments Data

Michael Guss, MD

Orthopaedic Surgery · Newton, MANPI 1063773711

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (52.9%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Medical Device Business Services, Inc. accounts for 61.5% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2020 at $5,838 and has fallen 76.3% since, to $1,386 in 2025.

$9,354in general payments, 2019–2025

Across 40 payments — averaging $233.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$6K
  • Arthrex$2K
  • Kairos Surgical Inc$583
  • Banner Surgical Solutions, Inc$447
  • Ossio Inc$167
  • Acumed LLC$166
  • plus $342 from 7 others

What the payments were for

  • Consulting fees$4,95053%
  • Travel & lodging$2,22124%
  • Food & beverage$1,28414%
  • Education$89910%

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,354 in reported general payments places this provider in the 65th percentile of 542 orthopaedic surgery providers in Massachusetts.

See all orthopaedic surgery providers in Massachusetts →

Medicare billing

Part B allowed, 2024
$295,480
Medicare patients
497
Services billed
2,868

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Methylprednisolone11$56

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Newton

See the full list for Massachusetts →

Where these figures come from

Is this you, or does something look wrong? →